estradiol-3-glucuronide and Fibrocystic-Breast-Disease

estradiol-3-glucuronide has been researched along with Fibrocystic-Breast-Disease* in 1 studies

Other Studies

1 other study(ies) available for estradiol-3-glucuronide and Fibrocystic-Breast-Disease

ArticleYear
beta-Glucuronidase levels in patients with fibrocystic breast disease.
    Breast cancer research and treatment, 1986, Volume: 8, Issue:3

    Certain enzymes in tissues and body fluids may, through reversal of the detoxification process, influence the composition and availability of steroid hormones, toxins, and carcinogens. The ubiquitous enzyme beta-glucuronidase, which hydrolyzes glucuronide conjugates, thereby reversing one of the main detoxification and excretion pathways, was found to vary in concentration in different cysts over a 300-fold range. The distribution was a continuum, devoid of discrete sub-populations. Evidence obtained on selected cyst fluids of high and low beta-glucuronidase activities indicated that the level of the enzyme significantly influenced the ratio of unconjugated: glucuronidated estradiol. The patients with fibrocystic breast disease fell into 2 distinct subpopulations on the basis of their serum beta-glucuronidase activity. In one group the activity was near normal, while in the second group the average serum beta-glucuronidase activity was 3-fold higher than in the women who did not have benign breast disease.

    Topics: Adult; Aged; Estradiol; Exudates and Transudates; Female; Fibrocystic Breast Disease; Glucuronidase; Humans; Middle Aged

1986